The impact of the COVID-19 pandemic on people with epilepsy and epilepsy specialists

被引:2
作者
Zhang, Ning [1 ,2 ]
Niu, Cailang [3 ]
Li, Penghong [3 ]
Du, Xueqing [3 ]
Zhao, Mina [3 ]
Li, Mao [1 ,2 ]
Jing, Wei [1 ,2 ]
机构
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Neurol, Taiyuan 030032, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Peoples R China
[3] Shanxi Med Univ, Hosp 3, Shanxi Bethune Hosp, Shanxi Acad Med Sci,Tongji Shanxi Hosp,Dept Neurol, Taiyuan 030032, Peoples R China
关键词
COVID-19; pandemic; People with epilepsy; Diagnostic delay; Prescription habits; Seizure increase; ANTIEPILEPTIC DRUG EFFICACY; INITIAL MONOTHERAPY; LEVETIRACETAM; SEIZURES;
D O I
10.1016/j.yebeh.2023.109389
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, the global population experienced changes in diagnosis and treatment patterns. The aim of this study was to evaluate the influence of the COVID-19 pandemic on people with epilepsy (PWE) and epilepsy specialists in China.Methods: We retrospectively evaluated newly diagnosed PWE from January 2018 to January 2022 at Shanxi Bethune Hospital. The clinical characteristics of PWE and the prescription habits of epilepsy specialists were analyzed. We also explored changes in seizure control among PWE as a result of the COVID19 pandemic and assessed the possible causes. Results: After excluding 49 PWE who were lost to follow-up, 421 PWE were included in the study. They were divided into a prepandemic group and a pandemic group, with December 2019 as the boundary. By comparing the two groups, we found that the duration between first symptom detection and diagnosis was longer in the pandemic group than in the prepandemic group. Epilepsy specialists preferred prescribing the fast-acting antiepileptic drug levetiracetam (LEV) in the pandemic group. During the COVID-19 pandemic, 49.57% of PWE reported difficulties in accessing their epilepsy healthcare provider, and 26.96% reported that appointments with their providers occurred as usual. A lack of anti-seizure medication (ASM) availability was reported by 32.17% of subjects. An increase in seizure frequency was noted in 25.22% of the PWE during the pandemic. The factors increasing seizure frequency during the pandemic were fear of COVID-19, exacerbation of mental states, sleep deprivation, cancelation of regular medical visits, difficulties accessing epilepsy healthcare providers, and a lack of ASM availability.Conclusion: The COVID-19 pandemic exposed PWE to harmful consequences mainly due to medical shortages and worse life states. During the pandemic, there were delays in the diagnosis of PWE, and doctors' prescription habits changed. We must consider the lessons learned during this period of social restrictions and employ recent technological advances to improve treatment for PWE. & COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 45 条
[1]   Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States [J].
Ahrens, Stephanie M. ;
Ostendorf, Adam P. ;
Lado, Fred Alexander ;
Arnold, Susan T. ;
Bai, Shasha ;
Bensalem-Owen, Meriem K. ;
Chapman, Kevin E. ;
Clarke, Dave F. ;
Eisner, Mariah ;
Fountain, Nathan B. ;
Gray, Johanna M. ;
Gunduz, Muhammed Talha ;
Hopp, Jennifer L. ;
Riker, Ellen ;
Schuele, Stephan U. ;
Small, Barbara ;
Herman, Susan T. .
NEUROLOGY, 2022, 98 (19) :E1893-E1901
[2]   Impact of COVID-19 pandemic on pediatric patients with epilepsy in Jordan: The caregiver perspective [J].
Al Momani, Miral ;
Almomani, Basima A. ;
Sweidan, Philip ;
Al-Qudah, Aladdin ;
Aburahma, Samah ;
Arafeh, Yusra .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 92 :100-105
[3]   Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective [J].
Aledo-Serrano, Angel ;
Mingorance, Ana ;
Jimenez-Huete, Adolfo ;
Toledano, Rafael ;
Garcia-Morales, Irene ;
Anciones, Carla ;
Gil-Nagel, Antonio .
EPILEPSIA, 2020, 61 (06) :1312-1314
[4]   Missed, mistaken, stalled: Identifying components of delay to diagnosis in epilepsy [J].
Alessi, Natasha ;
Perucca, Piero ;
McIntosh, Anne M. .
EPILEPSIA, 2021, 62 (07) :1494-1504
[5]   The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy [J].
Alkhotani, Amal ;
Siddiqui, Muhammad, I ;
Almuntashri, Fahad ;
Baothman, Renad .
EPILEPSY & BEHAVIOR, 2020, 112
[6]   Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients [J].
Amare, Amanuel ;
Zenebe, Guta ;
Hammack, Julie ;
Davey, Gail .
EPILEPSIA, 2008, 49 (04) :600-607
[7]   Understanding and managing the impact of the COVID-19 pandemic and lockdown on patients with epilepsy [J].
Assenza, Giovanni ;
Ricci, Lorenzo ;
Lanzone, Jacopo ;
Boscarino, Marilisa ;
Vico, Carlo ;
Narducci, Flavia ;
Sancetta, Biagio ;
Di Lazzaro, Vincenzo ;
Tombini, Mario .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (02) :145-153
[8]   Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening [J].
Assenza, Giovanni ;
Lanzone, Jacopo ;
Brigo, Francesco ;
Coppola, Antonietta ;
Di Gennaro, Giancarlo ;
Di Lazzaro, Vincenzo ;
Ricci, Lorenzo ;
Romigi, Andrea ;
Tombini, Mario ;
Mecarelli, Oriano .
FRONTIERS IN NEUROLOGY, 2020, 11
[9]   Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements [J].
Bandopadhyay, Ritam ;
Singh, Tanveer ;
Ghoneim, Mohammed M. ;
Alshehri, Sultan ;
Angelopoulou, Efthalia ;
Paudel, Yam Nath ;
Piperi, Christina ;
Ahmad, Javed ;
Alhakamy, Nabil A. ;
Alfaleh, Mohamed A. ;
Mishra, Awanish .
BIOLOGY-BASEL, 2021, 10 (11)
[10]   Status epilepticus and COVID-19: A systematic review [J].
Dono, Fedele ;
Nucera, Bruna ;
Lanzone, Jacopo ;
Evangelista, Giacomo ;
Rinaldi, Fabrizio ;
Speranza, Rino ;
Troisi, Serena ;
Tinti, Lorenzo ;
Russo, Mirella ;
Di Pietro, Martina ;
Onofrj, Marco ;
Bonanni, Laura ;
Assenza, Giovanni ;
Vollono, Catello ;
Anzellotti, Francesca ;
Brigo, Francesco .
EPILEPSY & BEHAVIOR, 2021, 118